Sinopharm to Inject $4.6 Bn Covid-19 Vaccine Assets Into Unit Tiantan Biological: Report
3 years, 11 months ago

Sinopharm to Inject $4.6 Bn Covid-19 Vaccine Assets Into Unit Tiantan Biological: Report

News 18  

Chinese state-owned Sinopharm plans to inject 30 billion yuan in assets into unit Beijing Tiantan Biological Products Corp Ltd to quickly get its fast-growing vaccine business on the public market, two people told Reuters. Sinopharm aims to begin the injection of six vaccine-focused biological products developers including makers of two COVID-19 vaccines into Shanghai-listed Tiantan in the coming weeks, said the people plus two other people with knowledge of the matter. The six units Sinopharm aims to inject into Tiantan develop and manufacture a range of vaccines including two for COVID-19 as well as injectable cosmetic Botox, their websites showed. One of the two COVID-19 vaccines, developed in Beijing, was the first approved for general public use in China in December, and has since gained emergency use approval in countries such as Iraq and Morocco.

History of this topic

Sino Biopharm targets 30 innovative products by 2027
1 week, 4 days ago
Mpox vaccine ready for clinical trial
3 months, 2 weeks ago
Mpox vaccine ready for clinical trial
3 months, 2 weeks ago
Large-scale COVID reemergence 'unlikely' despite uptick in cases
1 year, 10 months ago
Large-scale COVID reemergence 'unlikely' despite uptick in cases
1 year, 10 months ago
Large-scale COVID reemergence 'unlikely' despite uptick in cases
1 year, 10 months ago
China approves its first mRNA COVID-19 vaccine; here’s all you need to know
2 years ago
China approves its first mRNA vaccine for Covid-19
2 years ago
Vaccines from China bolster COVID fight
2 years, 1 month ago
No new Covid variants during recent breakout in China: Lancet study
2 years, 1 month ago
COVID-19 update: China faces challenge due to flawed containment policies, ineffective vaccines, says Report
2 years, 2 months ago
Coronavirus in China: 'Funding issues won’t stand in the way of medical treatment,' says government
2 years, 2 months ago
COVID-19 update: China reports nearly 60,000 coronavirus deaths since December 2022| DETAILS
2 years, 2 months ago
Chinese travellers head to Hong Kong for mRNA Covid vaccines: Report
2 years, 2 months ago
COVID In 2023: Here's What Experts Expect
2 years, 2 months ago
Six fallacies and truths about China's epidemic control
2 years, 2 months ago
No second Covid-19 booster dose required: Report
2 years, 2 months ago
Amid COVID surge, China approves America’s Paxlovid, an anti-viral drug: Why this is an unlikely move
2 years, 3 months ago
COVID-19: China races to vaccinate elderly amid rising cases, but many are reluctant
2 years, 3 months ago
China: Why older people are reluctant to get vaccinated despite rising COVID cases
2 years, 3 months ago
China races to vaccinate the elderly, but many are reluctant
2 years, 3 months ago
China sees nearly 37 million new Covid cases in one single day, says report
2 years, 3 months ago
Despite soaring cases, Chinese reluctant to take COVID vaccine amid fears of its potential side effects
2 years, 3 months ago
Nearly 250 million Covid-19 infections in China in just 20 days: Leaked doc
2 years, 3 months ago
After Slow Start, Demand for Covid-19 Booster Shots Spikes as China's New Wave Triggers Panic in India
2 years, 3 months ago
Explained: Are Chinese vaccines to blame for its COVID-19 surge?
2 years, 3 months ago
One-day tally of COVID cases in China hits 37 million: Report
2 years, 3 months ago
Prepare, don't panic, in the face of covid resurgence in China
2 years, 3 months ago
Big bonuses, extreme rationing: How Covid-hit China is coping with its drugs shortage
2 years, 3 months ago
A concerning sequence: The Hindu Editorial on a new coronavirus strain and a spurt in cases in China
2 years, 3 months ago
China says no new Covid deaths, but crematoriums ‘overwhelmed’ | Top points
2 years, 3 months ago
BioNTech-Pfizer COVID vaccine sent to China for Germans
2 years, 3 months ago
Rising COVID cases news from China is concerning: SII CEO Adar Poonawala, urges people not to panic
2 years, 3 months ago
China's recent coronavirus outbreak is a scathing indictment of its homemade vaccines
2 years, 3 months ago
'Rising Covid cases in China concerning,' says Serum Institute's Adar Poonawalla
2 years, 3 months ago
What is China's latest Covid situation? 5 points
2 years, 3 months ago
WHO chief ‘very concerned’ over COVID situation in China
2 years, 3 months ago
US concerned about ‘new mutations’ of virus from China's Covid outbreak
2 years, 3 months ago
Scary predictions on how many could die from Covid in China
2 years, 3 months ago
China’s COVID-19 outbreak has U.S. worried about new variants
2 years, 3 months ago
New COVID model predicts over 1 million deaths in China through 2023
2 years, 3 months ago
Inhalable COVID-19 vaccinations available in Shandong
2 years, 3 months ago
A week into easing, uncertainty over China virus direction
2 years, 3 months ago
China won’t report asymptomatic COVID cases in further shift
2 years, 3 months ago
In another big change, China says it won't report asymptomatic COVID cases
2 years, 3 months ago
Why vaccine hesitancy persists in China — and what they're doing about it
2 years, 3 months ago
China’s Beijing eases COVID curbs after rare protests
2 years, 3 months ago
China: Embracing a planned exit from zero-COVID strategy
2 years, 3 months ago
WHO Pleased to See China Ease Harsh Zero Covid Policies
2 years, 3 months ago
WHO pleased to see China ease harsh zero COVID policies
2 years, 3 months ago

Discover Related